Vetanco´s corporate site adds access to its Colombia subsidiary site

Vetanco, an international veterinary laboratory that for over 30 years has been developing, manufacturing and [...]

Vetanco at the CRWAD Conference

Our specialists participated in the “Conference of Research Workers in Animal Diseases 2020” held virtually [...]

INCUINTA and Bioinnovo apply their knowledge to fight COVID19

Argentine researchers used two different platforms to neutralize the virus with “nanobodies” derived from llamas [...]

Bioinnovo will increase production of the vaccine against Bovine Viral Diarrhea Virus

Bioinnovo, a public-private partnership between INTA and Vetanco S.A., will allocate an important support, granted by the Ministry [...]

A new achievement in the fight against COVID-19

A multidisciplinary team, where Bioinnovo SA participates, developed IgY avian antibodies that neutralize the COVID-19 [...]

Vetanco and Bioinnovo congratulate the company Algenex on a new achievement

Algenex, the Spanish company delivering recombinant technologies, a key factor for the development of Vedevax BLOCK, [...]

Bovine Viral Diarrhea: the Argentinian vaccine will be sold in Peru

The Andean Country authorized the commercialization of Vedevax Block, the first recombinant vaccine for the control [...]

100% Argentinian technology for the COVID-19 test

Specialists of the National Institute of Industrial Technology (INTI) and the national company Ivema Desarrollos designed an [...]

Vetanco develops an alliance with the UDESC

The constant Research and Development is a principle of Vetanco DNA and the reason why [...]

Sherry Layton, Vetanco USA Inc. CSO, was invited to give a presentation at Vaccines 2020

Due to the rising interest in Biotech Vac. Technology, Sherry Layton, Chief Scientific Officer of [...]